Mohammadali Habibi1, Harjit Chahal1, Anders Opdahl2, Ola Gjesdal2, Thomas M Helle-Valle3, Susan R Heckbert4, Robyn McClelland5, Colin Wu6, Steven Shea7, Gregory Hundley8, David A Bluemke9, João A C Lima10. 1. Cardiology Division, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland. 2. Cardiology Division, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland; Department of Cardiology, University of Oslo, Oslo, Norway. 3. Department of Cardiology, University of Oslo, Oslo, Norway. 4. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington. 5. Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington. 6. Office of Biostatistics, National Heart, Lung, and Blood Institute, Bethesda, Maryland. 7. Columbia University Medical Center, New York, New York. 8. Cardiology Section, Wake Forest University School of Medicine, Winston-Salem, North Carolina. 9. Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Maryland. 10. Cardiology Division, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland. Electronic address: jlima@jhmi.edu.
Abstract
OBJECTIVES: The goal of this study was to assess the association between left atrial (LA) volume and function measured with feature-tracking cardiac magnetic resonance (CMR) and development of heart failure (HF) in asymptomatic individuals. BACKGROUND: Whether alterations of LA structure and function precede or follow HF development remains incompletely understood. We hypothesized that significant alterations of LA deformation and architecture precede the development of HF in the general population. METHODS: In a case-control study nested in MESA (Multi-Ethnic Study of Atherosclerosis), baseline LA volume and function assessed using CMR feature-tracking were compared between 112 participants with incident HF (mean age 68.4 ± 8.2 years; 66% men) and 224 age- and sex-matched controls (mean age 67.7 ± 8.9 years; 66% men). Participants were followed up for 8 years. All individuals were in normal sinus rhythm at the time of imaging, without any significant valvular abnormalities and free of clinical cardiovascular diseases. RESULTS: Individuals with incident HF had greater maximal and minimal LA volume indexes (LAVImin) than control subjects (40 ± 13 mm(3)/m(2) vs. 33 ± 10 mm(3)/m(2) [p <0.001] for maximal LA index and 25 ± 11 mm(3)/m(2) vs. 17 ± 7 mm(3)/m(2) [p <0.001] for LAVImin). The HF case subjects also had smaller global peak longitudinal atrial strain (PLAS) (25 ± 11% vs. 38 ± 16%; p <0.001) and lower LA emptying fraction (40 ± 11% vs. 48 ± 9%; p <0.001) at baseline. After adjustment for traditional cardiovascular risk factors, left ventricular mass, and N-terminal pro-B-type natriuretic peptide, global PLAS (odds ratio: 0.36 per SD [95% confidence interval: 0.22 to 0.60]) and LAVImin (odds ratio: 1.65 per SD [95% confidence interval: 1.04 to 2.63]) were independently associated with incident HF. CONCLUSIONS: Deteriorations in LA structure and function preceded development of HF. Lower global PLAS and higher LAVImin, measured using CMR feature-tracking, were independent markers of incident HF in a multiethnic population of asymptomatic individuals.
OBJECTIVES: The goal of this study was to assess the association between left atrial (LA) volume and function measured with feature-tracking cardiac magnetic resonance (CMR) and development of heart failure (HF) in asymptomatic individuals. BACKGROUND: Whether alterations of LA structure and function precede or follow HF development remains incompletely understood. We hypothesized that significant alterations of LA deformation and architecture precede the development of HF in the general population. METHODS: In a case-control study nested in MESA (Multi-Ethnic Study of Atherosclerosis), baseline LA volume and function assessed using CMR feature-tracking were compared between 112 participants with incident HF (mean age 68.4 ± 8.2 years; 66% men) and 224 age- and sex-matched controls (mean age 67.7 ± 8.9 years; 66% men). Participants were followed up for 8 years. All individuals were in normal sinus rhythm at the time of imaging, without any significant valvular abnormalities and free of clinical cardiovascular diseases. RESULTS: Individuals with incident HF had greater maximal and minimal LA volume indexes (LAVImin) than control subjects (40 ± 13 mm(3)/m(2) vs. 33 ± 10 mm(3)/m(2) [p <0.001] for maximal LA index and 25 ± 11 mm(3)/m(2) vs. 17 ± 7 mm(3)/m(2) [p <0.001] for LAVImin). The HF case subjects also had smaller global peak longitudinal atrial strain (PLAS) (25 ± 11% vs. 38 ± 16%; p <0.001) and lower LA emptying fraction (40 ± 11% vs. 48 ± 9%; p <0.001) at baseline. After adjustment for traditional cardiovascular risk factors, left ventricular mass, and N-terminal pro-B-type natriuretic peptide, global PLAS (odds ratio: 0.36 per SD [95% confidence interval: 0.22 to 0.60]) and LAVImin (odds ratio: 1.65 per SD [95% confidence interval: 1.04 to 2.63]) were independently associated with incident HF. CONCLUSIONS: Deteriorations in LA structure and function preceded development of HF. Lower global PLAS and higher LAVImin, measured using CMR feature-tracking, were independent markers of incident HF in a multiethnic population of asymptomatic individuals.
Authors: Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: John S Gottdiener; Dalane W Kitzman; Gerard P Aurigemma; Alice M Arnold; Teri A Manolio Journal: Am J Cardiol Date: 2005-11-15 Impact factor: 2.778
Authors: Martin Osranek; Francesca Bursi; Kent R Bailey; Brandon R Grossardt; Robert D Brown; Stephen L Kopecky; Teresa S Tsang; James B Seward Journal: Eur Heart J Date: 2005-09-01 Impact factor: 29.983
Authors: Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke Journal: AJR Am J Roentgenol Date: 2006-06 Impact factor: 3.959
Authors: J M Gardin; R McClelland; D Kitzman; J A Lima; W Bommer; H S Klopfenstein; N D Wong; V E Smith; J Gottdiener Journal: Am J Cardiol Date: 2001-05-01 Impact factor: 2.778
Authors: Talhat Azemi; Vimal M Rabdiya; Srilatha R Ayirala; Louise D McCullough; David I Silverman Journal: J Am Soc Echocardiogr Date: 2012-10-12 Impact factor: 5.251
Authors: David A Bluemke; Richard A Kronmal; João A C Lima; Kiang Liu; Jean Olson; Gregory L Burke; Aaron R Folsom Journal: J Am Coll Cardiol Date: 2008-12-16 Impact factor: 24.094
Authors: Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert Journal: Eur Heart J Date: 2007-04-11 Impact factor: 29.983
Authors: Kanna Posina; Jeannette McLaughlin; Peter Rhee; Laura Li; Joshua Cheng; William Schapiro; Ronald J Gulotta; Andrew D Berke; George A Petrossian; Nathaniel Reichek; Jie J Cao Journal: J Cardiovasc Magn Reson Date: 2013-10-29 Impact factor: 5.364
Authors: Rocio Hinojar; Jose Luis Zamorano; MªAngeles Fernández-Méndez; Amparo Esteban; Maria Plaza-Martin; Ariana González-Gómez; Alejandra Carbonell; Luis Miguel Rincón; Jose Julio Jiménez Nácher; Covadonga Fernández-Golfín Journal: Int J Cardiovasc Imaging Date: 2019-01-31 Impact factor: 2.357
Authors: Flora Huang; Philip W Connelly; G V Ramesh Prasad; Michelle M Nash; Lakshman Gunaratnam; Djeven P Deva; Charmaine E Lok; Weiqiu Yuan; Rachel M Wald; Tamar Shalmon; Ron Wald; Kim A Connelly; Andrew T Yan Journal: J Nephrol Date: 2020-09-10 Impact factor: 3.902